Category: Guidelines

Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations

Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products

Expedited Programs for Regenerative Medicine Therapies for Serious Conditions

Computer Software Assurance for Production and Quality System Software

CVM GFI #299 -Dual Labeling for Fully Approved and Conditionally Approved New Animal Drugs with a New World Screwworm-Related Indication

Technical Specifications for Submitting Clinical Trial Data Sets for Response Assessments for Treatments of Acute Leukemias

Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers

Quality Management System Information for Certain Premarket Submission Reviews

Menstrual Products – Performance Testing and Labeling Recommendations